PCA
NUVB icon

Pallas Capital Advisors’s Nuvation Bio NUVB Stock Holding History

Pallas Capital Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
44,201
+119
+0.3% +$582 0.01% 817
2026
Q1 		$189K Sell
44,082
-1,691
-4% -$9.42K 0.01% 776
2025
Q4 		$410K Hold
45,773
– – 0.01% 592
2025
Q3 		$169K Buy
45,773
+3,454
+8% +$9.41K 0.01% 800
2025
Q2 		$82.5K Buy
42,319
+22,040
+109% +$45.9K ﹤0.01% 803
2025
Q1 		$35.7K Buy
20,279
+3,263
+19% +$7.43K ﹤0.01% 736
2024
Q4 		$45.3K Buy
17,016
+1,082
+7% +$2.79K ﹤0.01% 575
2024
Q3 		$36.6K Buy
15,934
+2,577
+19% +$7.86K ﹤0.01% 593
2024
Q2 		$42.5K Buy
13,357
+1,788
+15% +$5.46K ﹤0.01% 497
2024
Q1 		$42.1K Buy
11,569
+1,569
+16% +$3.01K ﹤0.01% 427
2023
Q4 		$15.1K Sell
10,000
-284
-3% -$365 ﹤0.01% 355
2023
Q3 		$10.3K Hold
10,284
– – ﹤0.01% 344
2023
Q2 		$17.5K Buy
10,284
+284
+3% +$483 ﹤0.01% 258
2023
Q1 		$17.5K Hold
10,000
– – ﹤0.01% 268
2022
Q4 		$23.6K Hold
10,000
– – ﹤0.01% 266
2022
Q3 		$21K Hold
10,000
– – ﹤0.01% 250
2022
Q2 		$31K Hold
10,000
– – ﹤0.01% 224
2022
Q1 		$55K Buy
+10,000
New +$56.2K 0.01% 231

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Pallas Capital Advisors's NUVB Position: Q2 2026 in Review

Pallas Capital Advisors increased its Nuvation Bio (NUVB) stake by 0.27% in Q2 2026, buying an estimated $582 and bringing the position to 44,201 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #817.

Pallas Capital Advisors first reported a position in NUVB in Q1 2022 and has held it in 18 quarters since. The position peaked at $410K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Pallas Capital Advisors held 44,201 shares of Nuvation Bio worth $251K as of Q2 2026.
  • Pallas Capital Advisors bought 119 Nuvation Bio shares in Q2 2026, an estimated $582.
  • Nuvation Bio made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #817 holding.
  • Pallas Capital Advisors first reported a position in Nuvation Bio in Q1 2022 and has held it in 18 quarters since.
  • Pallas Capital Advisors's Nuvation Bio position peaked at $410K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.